Alexandra Balcom

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Nathan McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra Balcom:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Chief Financial Officer Class A Common Stock 99,233 $9,981,946 $100.59 07 Jan 2026 Direct
Nuvalent, Inc. Chief Financial Officer Stock Option (Right to Buy) 17,500 07 Jan 2026 Direct
GLYCOMIMETICS INC Director Stock Option (Right to Buy) 9,023 23 Jun 2025 Direct

Insider Reports Filed by Alexandra Balcom

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 05 Jan 2026 9 -$721,320 4 Chief Financial Officer 07 Jan 2026, 17:25
NUVL Nuvalent, Inc. 22 Dec 2025 2 +$37,260 4 Chief Financial Officer 23 Dec 2025, 16:30
NUVL Nuvalent, Inc. 08 Dec 2025 2 -$781,537 4 Chief Financial Officer 10 Dec 2025, 16:30
NUVL Nuvalent, Inc. 17 Nov 2025 14 -$1,015,325 4 Chief Financial Officer 19 Nov 2025, 17:14
NUVL Nuvalent, Inc. 15 Oct 2025 3 -$112,155 4 Chief Financial Officer 17 Oct 2025, 16:31
NUVL Nuvalent, Inc. 13 Oct 2025 13 -$2,819,878 4 Chief Financial Officer 15 Oct 2025, 16:30
NUVL Nuvalent, Inc. 01 Oct 2025 6 -$1,533,027 4 Chief Financial Officer 03 Oct 2025, 16:28
NUVL Nuvalent, Inc. 29 Sep 2025 6 -$2,156,175 4 Chief Financial Officer 01 Oct 2025, 20:17
NUVL Nuvalent, Inc. 15 Jul 2025 9 -$1,314,896 4 Chief Financial Officer 17 Jul 2025, 16:32
NUVL Nuvalent, Inc. 27 Jun 2025 3 -$1,221,800 4 Chief Financial Officer 01 Jul 2025, 16:30
CBIO GLYCOMIMETICS INC 23 Jun 2025 1 $0 4 Director 23 Jun 2025, 18:43
CBIO GLYCOMIMETICS INC 13 Jun 2025 0 $0 3 Director 23 Jun 2025, 18:23
NUVL Nuvalent, Inc. 06 Jan 2025 5 -$320,009 4 Chief Financial Officer 08 Jan 2025, 16:48
NUVL Nuvalent, Inc. 17 Dec 2024 4 +$66,923 4 Chief Financial Officer 18 Dec 2024, 16:53
NUVL Nuvalent, Inc. 29 Nov 2024 4 -$679,440 4 Chief Financial Officer 03 Dec 2024, 16:46
NUVL Nuvalent, Inc. 31 Oct 2024 6 -$613,379 4 Chief Financial Officer 04 Nov 2024, 16:46
NUVL Nuvalent, Inc. 30 Sep 2024 6 -$732,120 4 Chief Financial Officer 02 Oct 2024, 17:33
NUVL Nuvalent, Inc. 30 Aug 2024 5 -$563,849 4 Chief Financial Officer 04 Sep 2024, 16:52
NUVL Nuvalent, Inc. 31 Jul 2024 7 -$516,574 4 Chief Financial Officer 02 Aug 2024, 16:43
NUVL Nuvalent, Inc. 28 Jun 2024 5 -$475,841 4 Chief Financial Officer 02 Jul 2024, 16:44
NUVL Nuvalent, Inc. 05 Jan 2024 2 $0 4 Chief Financial Officer 09 Jan 2024, 16:49
NUVL Nuvalent, Inc. 18 Dec 2023 3 -$2,242,200 4 Chief Financial Officer 20 Dec 2023, 16:51
NUVL Nuvalent, Inc. 31 Jul 2023 4 -$1,197,796 4 Chief Financial Officer 01 Aug 2023, 16:16
NUVL Nuvalent, Inc. 06 Jan 2023 1 $0 4 Chief Financial Officer 06 Jan 2023, 15:45
NUVL Nuvalent, Inc. 04 Jan 2022 1 $0 4 Chief Financial Officer 05 Jan 2022, 16:07
NUVL Nuvalent, Inc. 28 Jul 2021 0 $0 3 Chief Financial Officer 28 Jul 2021, 21:31